MoneyWorks4Me

Wanbury - Quaterly Results

08 Feb 2022 Evaluate
A fair growth of 13.80% in the revenue at Rs. 1248.36 millions was reported in the December 2021 quarter as compared to Rs. 1097.00 millions during year-ago period.Net profit was down at Rs. 3.73  millions against Rs. 59.11 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -93.69%.Operating profit for the quarter ended December 2021 decreased to 90.95 millions as compared to 145.64 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1248.36 1097.00 13.80 3767.92 2720.70 38.49 3925.18 3674.55 6.82
Other Income 2.55 8.02 -68.20 8.67 11.92 -27.27 24.04 11.40 110.88
PBIDT 90.95 145.64 -37.55 233.66 209.79 11.38 204.23 245.85 -16.93
Interest 56.37 62.10 -9.23 158.21 172.86 -8.48 230.75 328.71 -29.80
PBDT 34.58 83.54 -58.61 75.45 36.93 104.31 -26.52 743.54 -103.57
Depreciation 30.30 23.92 26.67 84.49 71.67 17.89 97.54 96.84 0.72
PBT 4.28 59.62 -92.82 -9.04 -34.74 -73.98 -124.06 646.70 -119.18
TAX 0.55 0.51 7.84 1.67 1.75 -4.57 2.00 2.09 -4.31
Deferred Tax 0.55 0.51 7.84 1.67 1.75 -4.57 -20.68 2.09 -1089.47
PAT 3.73 59.11 -93.69 -10.71 -36.49 -70.65 -126.06 644.61 -119.56
Equity 326.66 250.15 30.59 326.66 250.15 30.59 250.15 249.95 0.08
PBIDTM(%) 7.29 13.28 -45.12 6.20 7.71 -19.58 5.20 6.69 -22.23
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..